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A terbium-activated gadolinium oxysulfide 
(Gd2O2S:Tb) intensifying screen increases the sensitivi-
ty of x-ray film by a factor of 2 when compared to a 
standard calcium tungstate (CaW04) screen. Optimizing 
the film to this new x-ray phosphor can increase film 
sensitivity by a factor of 20. Consequently, x-ray ex-
posure can be reduced comparably without changing 
the quality of present images.
Terbium-activated gadolinium oxysulfide has over 
five times the intrinsic luminescense efficiency of 
CaW04 , with its emissions primarily in the green spec-
tral range near 5400 A. Calcium tungstate, on the other 
hand, emits a broadband which peaks in the blue spec-
0 tral range near 4200 A. The figure compares the two 
spectra; the CaW04 intensity scale is expanded for 
clarity.
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The spectral sensitivity of medical x-ray film (see 
figure) has developed over the years to match the blue 
emission from CaW04 . The sensitivity range of this 
blue-sensitive film does not include the principle emis-
sion from Gd202S:Tb. There does exist, however, a 
green-sensitive film with the spectral sensitivity range 
shown. Using the green-sensitive film with a Gd2O2S:Tb 
screen, 1/18 of the x-ray exposure is needed to get film 
darkening equivalent to that obtained using a CaWO4 
screen. Using the blue-sensitive film with a Gd202S:Tb 
screen, 1/2 the exposure is neededfor equivalent dark-
ening. An even larger exposure reduction (about 1/20 
of that presently required) will be possible when a new 
photographic film with maximum sensitivity near 5400 A 
is developed for the new screens. 
The new x-ray intensifying screen may make 
possible new radiographic procedures where detection 
speed and x-ray tube power have previously been the 
limiting factors. It will also significantly reduce the 
total population exposure to harmful radiation in the 
United States.
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